The U.S. Food and Drug Administration announced the approval of the first hematopoietic stem cell transplant therapy to treat ...

Motixafortide alone and in combination with natalizumab can support the collection of the large number of stem cells required ...

Patients with <7/8 transplants had a 1-year survival of 85.6% versus 78.6% for those who received better-matched donor cells.

QuantumScape has completed the installation of key equipment to enable higher-volume QSE-5 cell production – a key goal for ...

Indiana schools already ban cell phones during instructional time, but a new proposal would lock them away for the entire day ...

Gamida Cell has scored an expansion for Omisirge, with the FDA endorsing the stem cell-based therapy to treat severe aplastic ...

Kylie Jenner recently traveled to Mexico to undergo stem cell therapy for her chronic back pain. Experts say that while the ...

Exicure’s investigational small molecule succeeded in mobilizing key blood-forming cells in almost 90% of patients in a phase ...

This study provides useful insights into addressing the question of whether the prevalence of autoimmune disease could be driven by sex differences in the T cell receptor (TCR) repertoire, correlating ...

The Kardashian sister wrote on Instagram that she had been dealing with chronic back pain for nearly three years, after ...

New three-year follow-up results from the TRANSCEND FL trial show that patients with relapsed or refractory follicular ...

Some California policymakers and prison officials contend that offering more single-occupancy cells might serve the best ...